Sangamo Therapeutics
SGMO
#10632
Rank
NZ$53.55 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-86.23%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.19 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion0.31%
2025 -NZ$0.19 Billion9.71%
2024 -NZ$0.18 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.36 Billion9.79%
2021 -NZ$0.33 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$98.47 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$81.86 Million75.62%
2014 -NZ$46.62 Million0.13%
2013 -NZ$46.56 Million
2011 -NZ$62.58 Million43.66%
2010 -NZ$43.57 Million28.52%
2009 -NZ$33.9 Million-23.55%
2008 -NZ$44.34 Million2.45%
2007 -NZ$43.28 Million19.5%
2006 -NZ$36.22 Million50.78%
2005 -NZ$24.02 Million75%
2004 -NZ$13.73 Million-33.25%
2003 -NZ$20.57 Million-62.27%
2002 -NZ$54.5 Million102.82%
2001 -NZ$26.87 Million23.21%
2000 -NZ$21.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.87 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.83 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.42 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.74 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.97 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.51 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA